Wilms' tumor
From Wikipedia, the free encyclopedia
| ICD-10 | C64. |
|---|---|
| ICD-9 | 189.0 |
| ICD-O: | M8960/3 |
| OMIM | 194070 607102 |
| DiseasesDB | 8896 |
| eMedicine | med/3093 ped/2440 |
| MeSH | D009396 |
Wilms' tumor is a neoplasm of the kidneys that typically occurs in children. It is eponymously named after Dr. Max Wilms [1], a German surgeon (1867-1918) who first identified this form of cancer. It is also known as a nephroblastoma.
Approximately 500 cases are diagnosed in the U.S. annually. The majority (75%) occur in otherwise normal children; a minority (25%) is associated with other developmental abnormalities. It is highly responsive to treatment, with about 90% of patients surviving at least five years.
Contents |
[edit] Presentation
Wilms' tumor can affect any child regardless of race, sex, country of origin, or parental occupation. The disease is mostly noticed around age three, but has been recorded in people at the age of 21. Most cases begin with experience of the following symptoms:
- Abdominal mass
- Haematuria (Blood in the urine)
- Fever
- and less frequent anorexia, vomiting, and malaise
It can be associated with a WAGR complex. This complex includes Wilms' Tumor, aniridia, genitourinary malformation, and mental motor retardation. It can also be associated with Beckwith-Wiedemann syndrome (hemihypertrophy, macroglossia, omphalocele).
[edit] Pathology
Pathologically, a triphasic nephroblastoma comprises three elements:
Wilms' tumor is a malignant tumor containing metanephric blastema, stromal and epithelial derivatives. Characteristic is the presence of abortive tubules and glomeruli surrounded by a spindled cell stroma. The stroma may include striated muscle, cartilage, bone, fat tissue, fibrous tissue. The tumor is compressing the normal kidney parenchyma. [2]
The mesenchymal component may include cells showing rhabdomyoid differentiation. The rhabdomyoid component may itself show features of malignancy (rhabdomyosarcomatous Wilms).
Wilms tumor may be separated into 2 prognostic groups based on pathologic characteristics:
- Favorable - Contains well developed components mentioned above
- Anaplastic - Contains diffuse anaplasia (poorly developed cells)
[edit] Staging and treatment
Staging is determined by combination of imaging studies, and pathologic findings if the tumor is operable (adapted from www.cancer.gov). Treatment strategy is determined by the stage:
[edit] Stage I (43% of patients)
For stage I Wilms' tumor, 1 or more of the following criteria must be met: - Tumor is limited to the kidney and is completely excised. - The surface of the renal capsule is intact. - The tumor is not ruptured or biopsied (open or needle) prior to removal. - No involvement of renal sinus vessels. - No residual tumor apparent beyond the margins of excision.
Treatment: Nephrectomy + 18 weeks of chemotherapy
Outcome: 98% 4-year survival; 85% 4-year survival if anaplastic
[edit] Stage II (23% of patients)
For Stage II Wilms' tumor, 1 or more of the following criteria must be met: - Tumor extends beyond the kidney but is completely excised. - No residual tumor apparent at or beyond the margins of excision. - Any of the following conditions may also exist: -- Tumor involvement of the blood vessels of the renal sinus and/or outside the renal parenchyma. -- The tumor has been biopsied prior to removal or there is local spillage of tumor during surgery, confined to the flank.
Treatment: Nephrectomy + abdominal radiation + 24 weeks of chemotherapy
Outcome: 96% 4-year survival; 70% 4-year survival if anaplastic
[edit] Stage III (23% of patients)
For Stage III Wilms' tumor, 1 or more of the following criteria must be met: - Unresectable primary tumor. - Lymph node metastasis. - Positive surgical margins. - Tumor spillage involving peritoneal surfaces either before or during surgery, or transected tumor thrombus.
Treatment: Abdominal radiation + 24 weeks of chemotherapy + nephrectomy after tumor shrinkage
Outcome: 95% 4-year survival; 56% 4-year survival if anaplastic
[edit] Stage IV (10% of patients)
Stage IV Wilms’ tumor is defined as the presence of hematogenous metastases (lung, liver, bone, or brain), or lymph node metastases outside the abdomenopelvic region.
Treatment: Nephrectomy + abdominal radiation + 24 weeks of chemotherapy + radiation of metastatic site as appropriate
Outcome: 90% 4-year survival; 17% 4-year survival if anaplastic
[edit] Stage V (5% of patients)
Stage V Wilms’ tumor is defined as bilateral renal involvement at the time of initial diagnosis. Note: For patients with bilateral involvement, an attempt should be made to stage each side according to the above criteria (stage I to III) on the basis of extent of disease prior to biopsy. The 4-year survival was 94% for those patients whose most advanced lesion was stage I or stage II; 76% for those whose most advanced lesion was stage III.
Treatment: Individualized thereapy based on tumor burden
[edit] Stage I-IV Anaplasia
Children with stage I anaplastic tumors have an excellent prognosis (80-90% five-year survival). They can be managed with the same regimen given to stage I favorable histology patients.
Children with stage II through stage IV diffuse anaplasia, however, represent a higher-risk group. These tumors are more resistant to the chemotherapy traditionally used in children with Wilms’ tumor (favorable histology), and require more aggressive regimens.
[edit] See also
[edit] External links
- "Current Therapy for Wilms' Tumor" (2005) by Monika L. Metzger and Jeffrey S. Dome
- Information from National Cancer Institute
- Information from WebMD
- Information from the Mayo Clinic
- Information from "cancerbackup" (U.K.}
- Information from Sydney Children's Hospital (Australia)
- Photos from Atlas of Pathology
- List of additional resources compiled by the NIH
